ArticleMolecular therapy. Nucleic acids2025

MVA-HBVac-A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination.

Anna D Kosinska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.